Sperm protein 17 (Sp17) in multiple myeloma: opportunity for myeloma-specific donor T cell infusion to enhance graft-versus-myeloma effect without increasing graft-versus-host disease risk
Open Access
- 23 July 2001
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 31 (8) , 2277-2283
- https://doi.org/10.1002/1521-4141(200108)31:8<2277::aid-immu2277>3.0.co;2-z
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Sperm protein 17 is a novel cancer-testis antigen in multiple myelomaBlood, 2001
- Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalitiesBlood, 2000
- Expression of testicular genes in haematological malignanciesBritish Journal of Cancer, 1999
- Idiotypic protein-pulsed dendritic cell vaccination in multiple myelomaInternational Journal of Cancer, 1999
- Idiotype Vaccination in Human Myeloma: Generation of Tumor-Specific Immune Responses After High-Dose ChemotherapyBlood, 1999
- Idiotype Vaccination Using Dendritic Cells After Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma—A Feasibility StudyBlood, 1999
- New Paths in Human Cancer SerologyThe Journal of Experimental Medicine, 1998
- Idiotype Immunization Combined With Granulocyte-Macrophage Colony-Stimulating Factor in Myeloma Patients Induced Type I, Major Histocompatibility Complex–Restricted, CD8- and CD4-Specific T-Cell ResponsesBlood, 1998
- Cytotoxic T lymphocytes derived from bone marrow mononuclear cells of multiple myeloma patients recognize an underglycosylated form of MUC1 mucinInternational Immunology, 1997
- Mutational activation of N- and K-ras oncogenes in plasma cell dyscrasiasBlood, 1993